AI/ML Innovations Inc (AIML.CX)
0.06
0.00 (0.00%)
CAD |
CNSX |
May 17, 16:00
AI/ML Innovations Enterprise Value: 4.235M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 4.235M |
May 16, 2024 | 4.235M |
May 15, 2024 | 4.235M |
May 14, 2024 | 4.235M |
May 13, 2024 | 4.622M |
May 10, 2024 | 3.848M |
May 09, 2024 | 3.461M |
May 08, 2024 | 3.461M |
May 07, 2024 | 3.461M |
May 06, 2024 | 4.235M |
May 03, 2024 | 4.622M |
May 02, 2024 | 4.622M |
May 01, 2024 | 4.622M |
April 30, 2024 | 4.622M |
April 29, 2024 | 4.622M |
April 26, 2024 | 4.622M |
April 25, 2024 | 4.622M |
April 24, 2024 | 4.622M |
April 23, 2024 | 4.622M |
April 22, 2024 | 4.622M |
April 19, 2024 | 5.010M |
April 18, 2024 | 5.010M |
April 17, 2024 | 5.010M |
April 16, 2024 | 6.171M |
April 15, 2024 | 5.397M |
Date | Value |
---|---|
April 12, 2024 | 6.558M |
April 11, 2024 | 6.558M |
April 10, 2024 | 6.558M |
April 09, 2024 | 5.784M |
April 08, 2024 | 5.784M |
April 05, 2024 | 6.558M |
April 04, 2024 | 6.171M |
April 03, 2024 | 6.171M |
April 02, 2024 | 6.558M |
April 01, 2024 | 6.945M |
March 28, 2024 | 6.527M |
March 27, 2024 | 5.757M |
March 26, 2024 | 5.757M |
March 25, 2024 | 4.986M |
March 22, 2024 | 5.757M |
March 21, 2024 | 5.371M |
March 20, 2024 | 5.371M |
March 19, 2024 | 4.986M |
March 18, 2024 | 4.986M |
March 15, 2024 | 4.986M |
March 14, 2024 | 5.371M |
March 13, 2024 | 6.527M |
March 12, 2024 | 5.757M |
March 11, 2024 | 4.986M |
March 08, 2024 | 4.986M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.9779M
Minimum
Oct 25 2022
34.57M
Maximum
Feb 08 2021
6.479M
Average
3.966M
Median
Nov 20 2023
Enterprise Value Benchmarks
Biocure Technology Inc | 1.448M |
Core One Labs Inc | 8.808M |
Nova Mentis Life Science Corp | 2.183M |
Nanosphere Health Sciences Inc | 0.2445M |
Lobe Sciences Ltd | 3.658M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.5146M |
Revenue (Quarterly) | 0.1767M |
Total Expenses (Quarterly) | 0.5996M |
EPS Diluted (Quarterly) | -0.01 |
Gross Profit Margin (Quarterly) | 61.47% |
Profit Margin (Quarterly) | -291.3% |
Earnings Yield | -62.85% |
Normalized Earnings Yield | -61.24 |